Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

Off Script with William A. Van Decker, MD

News Opinion Off Script

One Big Beautiful Bill Act Doesn’t Spare Cardiology

William A. Van Decker, MD

August 04, 2025

COVID-19 Increases MACE Risk Nearly 3 Years Later: UK Biobank

News Daily News

COVID-19 Increases MACE Risk Nearly 3 Years Later: UK Biobank

October 10, 2024

Decades After WHI: Calcium, Vitamin D Linked to Different CVD, Cancer Outcomes

News Daily News

Decades After WHI: Calcium, Vitamin D Linked to Different CVD, Cancer Outcomes

March 12, 2024

Rethink Race in Pooled Cohort Equations for ASCVD, REGARDS Data Suggest

News Daily News

Rethink Race in Pooled Cohort Equations for ASCVD, REGARDS Data Suggest

December 11, 2023

Some Daylight for Vitamin D? New Analysis Hints at Small CVD Benefit

News Daily News

Some Daylight for Vitamin D? New Analysis Hints at Small CVD Benefit

Michael O'Riordan

June 30, 2023

From Cannabis to Opioids, Meth, and Cocaine: Drugs Are Linked to More AF

News Daily News

From Cannabis to Opioids, Meth, and Cocaine: Drugs Are Linked to More AF

October 27, 2022

COVID-19: TCTMD’s Dispatch for September 26

News Daily News

COVID-19: TCTMD’s Dispatch for September 26

September 26, 2022

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

News Daily News

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Yael L. Maxwell

June 23, 2022

Best Exercise for Heart Health? Some Hints of Intensity’s Role

News Daily News

Best Exercise for Heart Health? Some Hints of Intensity’s Role

Michael O'Riordan

December 02, 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

News Conference News AHA 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

November 15, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

October 13, 2021

IAMI: Influenza Vaccine Beneficial for Post-MI Patients

News Conference News ESC 2021

IAMI: Influenza Vaccine Beneficial for Post-MI Patients

Michael O'Riordan

August 30, 2021

CABG Loses Survival Advantage in Women at 10 Years: SYNTAXES

News Daily News

CABG Loses Survival Advantage in Women at 10 Years: SYNTAXES

Yael L. Maxwell

August 20, 2020

One Egg a Day? No Link to Risk of CVD, Mega-Meta-analysis Says

News Daily News

One Egg a Day? No Link to Risk of CVD, Mega-Meta-analysis Says

Michael O'Riordan

March 06, 2020

Habitual Use of Fish Oil Prevents CVD, Real-world Data Suggest

News Daily News

Habitual Use of Fish Oil Prevents CVD, Real-world Data Suggest

March 05, 2020

Most Supplements and Diets Don’t Lower CVD or Mortality Risks

News Daily News

Most Supplements and Diets Don’t Lower CVD or Mortality Risks

Michael O'Riordan

July 09, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.